Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glutamine for severe sepsis
ChiCTR-TRC-11001445Phase 4Completed
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of glutamine in sepsis (2 arms), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoint: 28-day survival rate. Started Apr 2011; status: completed.
02
Drugs
glutamine
03
Conditions
sepsis
Beyond the preview
Go deeper on ChiCTR-TRC-11001445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001445.